Director, Field Health Economics & Outcomes Research (HEOR) at Nuvalent, Inc.

Cambridge, Massachusetts, United States -

Full Time

Start Date

Immediate

Expiry Date

29 Apr, 26

Salary

250000.0

Posted On

29 Jan, 26

Experience

10 year(s) or above

Remote Job

Yes

Telecommute

Yes

Sponsor Visa

Skills

Health Economics, Outcomes Research, Oncology, Evidence Generation, Cross-Functional Collaboration, Strategic Planning, Data Generation, Payer Engagement, Economic Modeling, Decision Tools, Scientific Communication, Project Management, Statistical Analysis, Regulatory Knowledge, Market Access, Clinical Development

Industry

Biotechnology Research

Description

The Company: With deep expertise in chemistry, Nuvalent is working to create selective medicines designed with the goal to address the needs of patients with cancer. Nuvalent is an exciting early-stage company, bringing together experienced scientists and industry veterans with a proven track record in drug discovery, oncology drug development, and company building. Title: Director, Health Economics & Outcomes Research (HEOR) The Company: With deep expertise in chemistry, Nuvalent is creating selective medicines to address the needs of patients with cancer. Nuvalent is an exciting early-stage company, bringing together experienced scientists and industry veterans with a proven track record in drug discovery, oncology drug development, and company building. The Role: Reporting to the Senior Director, HEOR, the Director of Health Economics & Outcomes Research will lead U.S. and Global HEOR strategy for Nuvalent’s portfolio, shaping value evidence to enable optimal patient access and inform coverage, reimbursement, and utilization decisions. You will design and deliver HEOR/RWE studies, develop payer-facing economic/decision tools, support pre-, peri-, and post-launch planning, and foster cross-functional collaboration across Medical Affairs, Market Access, Regulatory, Commercial, Clinical Development, and Biostatistics. You’ll also play a visible role educating the organization on the evolving U.S. and Global HTA environment. This is an ideal opportunity for a scientifically strong, execution-oriented leader who enjoys pairing strategic planning with hands-on delivery in a fast-paced setting. Responsibilities: Strategy, Governance & Planning Lead the U.S. & Global HEOR strategy and integrated evidence planning for Nuvalent assets, aligned with Medical Affairs, Market Access, Regulatory, and Commercial priorities. Standardize and optimize data generation policies, processes, and SOPs to ensure quality, compliance, and scalability. Develop the annual HEOR tactical plan and budget; manage timelines, vendors, and scope to achieve defined objectives. Serve as the internal HEOR point of contact for evidence generation needs, services, and technologies; proactively represent payer/IDN evidence needs in cross-functional planning. Educate and upskill teams on HEOR, evidence-based medicine, U.S. reimbursement trends, and Global HTA dynamics. Evidence Generation & Publications Design, lead, and complete HEOR/RWE studies (e.g., observational studies, claims/EMR/registry analyses, PRO development/validation, burden of illness, unmet need). Own research plans, protocols, budgets, and timelines; oversee analyses and author abstracts, posters, manuscripts, and internal reports. Partner with Clinical Development and Biostatistics/Evidence Generation to optimize study design, endpoints, data sources, and analyses. Collaborate with Medical Information/Scientific Communications to inform U.S./Global publication plans and ensure consistent, compliant value messaging. Economic & Decision-Support Tools Lead development of AMCP/Global dossiers, Budget Impact Models (BIMs), Cost-Effectiveness Analyses (CEA), ITCs/NMAs, Systematic Literature Reviews (SLRs), and payer pull-through materials. Support ICER assessments and responses (as applicable) and monitor HTA implications (e.g., NICE, CADTH, etc.) for brand strategy. External Engagement & Field Support Identify and collaborate with KOLs/COEs on study design, authorship, and advisory boards; conduct payer advisory boards to track evolving evidence requirements. Engage payers, IDNs, PBMs, specialty pharmacies, and other decision makers via compliant scientific exchange to inform evidence needs and communicate value. Provide field-based scientific/HEOR support and tools to Market Access and medical field teams. Cross-Functional Partnership & Launch Excellence Partner with Brand/Commercial and Market Access to shape value narratives and pull-through while maintaining scientific integrity and compliance. Contribute to or lead high-priority medical initiatives, integrated evidence planning workshops, advisory boards, and cross-functional launch planning across U.S. and Global teams. Maintain in-depth knowledge of the evolving healthcare environment and HTA to anticipate evidence needs and inform strategy. Competencies: Strategic & hands-on: Equally comfortable setting strategy and rolling up sleeves to deliver. Collaboration & influence: Builds trust and productive relationships with internal leaders and external stakeholders. Innovation & problem solving: Encourages new ideas; integrates evidence from multiple sources to drive decisions. Operational excellence: Creates scalable capabilities, processes, and procedures; manages ambiguity and complexity. Results orientation: Performance-driven; proactively addresses risks, conflicts, and tradeoffs to deliver on time and on budget. Executive communication: Translates complex science and economics into clear, business-relevant insights. Qualifications: Doctoral degree (PhD, PharmD, MD/DO). 7–10+ years of relevant pharma/biotech HEOR/RWE experience. Oncology experience (3+ years), preferably NSCLC; U.S. and Global launch experience. Demonstrated expertise with U.S. and Global RWD (claims, EMR, registries) and payer landscapes. Hands-on experience with HEOR modeling (BIM/CEA), observational methods, and PROs; familiarity with statistics. Proven ability to work independently and collaboratively in fast-paced, cross-functional environments and manage multiple complex projects. Outstanding communication and presentation skills, including executive-level briefings and external thought leader engagement. U.S.-based remote role with periodic travel for internal meetings, congresses, advisory boards, and select payer/KOL engagements (~10–20% domestic; occasional international as needed). Preferred Experience supporting ICER and engaging with Global HTA bodies (e.g., NICE, CADTH). Track record building departmental capabilities, SOPs, and scalable vendor/operational frameworks. Established relationships across payers/IDNs/PBMs and oncology KOLs/COEs. Knowledge of medical communications trends and best practices. Additional Information: Nuvalent is committed to fair and equitable compensation practices, aiming to provide employees with competitive total rewards packages. The targeted salary range below reflects what Nuvalent reasonably and in good faith expects to offer for this position at the time of posting, but the final salary determination may be within or outside this range based on various factors, including, but not limited to, experience, skills, education, and market factors. The range will be reviewed regularly and is subject to change. Nuvalent also offers a comprehensive benefit package to support our employees at each stage of their career, financial, health, and well-being journey, including medical, dental, and vision insurance, 401(k) retirement savings plan, generous paid time off (including a summer and winter company shutdown), and much more. Nuvalent provides equal employment opportunities (EEO) to all employees and applicants for employment without regard to religion, race, creed, color, sex, sexual orientation, alienage or citizenship status, national origin, age, marital status, pregnancy, disability, veteran or military status, predisposing genetic characteristics or any other characteristic protected by applicable federal, state or local law. Annual Salary Range $220,000—$250,000 USD Nuvalent provides equal employment opportunities (EEO) to all employees and applicants for employment without regard to religion, race, creed, color, sex, sexual orientation, alienage or citizenship status, national origin, age, marital status, pregnancy, disability, veteran or military status, predisposing genetic characteristics or any other characteristic protected by applicable federal, state or local law. Nuvalent is aware that many companies are dealing with fraudulent job postings on third-party employment search sites and/or individual(s) or entities claiming to be employees of such companies. Those involved are offering fraudulent employment opportunities to applicants, often asking for sensitive personal and financial information, and using such information for criminal activities. Please be advised that all legitimate correspondence from a Nuvalent employee will come from "@nuvalent.com" email accounts. Automated system response emails from our Greenhouse applicant tracking system come from a “no-reply@greenhouse.io” email address. There are no variations of these email addresses and Nuvalent would not request personal and/or financial information via email. Job opportunities would only be extended after a completed job application is submitted by a candidate and a thorough interview process including 1:1 and/or group interviews via phone, video conferencing and/or in-person. If you believe you have been contacted by anyone misrepresenting themselves as an employee of Nuvalent, please contact Nuvalent at 857-357-7000. Thank you.

Responsibilities

The Director of Health Economics & Outcomes Research will lead U.S. and Global HEOR strategy, shaping value evidence to enable optimal patient access. Responsibilities include designing HEOR studies, developing economic tools, and fostering collaboration across various departments.